MedCity News May 24, 2023
Omada’s new program provides coaching, peer support and educational materials to patients struggling with chronic obesity and taking GLP-1s. The company chose not to prescribe the weight loss drugs itself.
Demand for GLP-1 drugs — which help patients feel fuller for longer and lose weight — is skyrocketing. In response, virtual healthcare provider Omada Health is launching a program that offers lifestyle and behavior support to patients who are struggling with chronic obesity and taking GLP-1s, the company announced Wednesday.
San Francisco-based Omada Health serves employers, health plans and health systems and provides virtual care for diabetes prevention, weight management, diabetes, hypertension, musculoskeletal issues and behavioral health.
The company chose not to prescribe GLP-1s itself, but is instead helping patients...
Today's Sponsors
Today's Sponsor